Histone Deacetylase Inhibition: An Important Mechanism in the Treatment of Lymphoma
Lymphomas encompass a group of malignancies that originate in the lymph nodes or other lymphoid tissues. Epigenetic modification, especially by histone deacetylase (HDACs), plays a key role during the occurrence and development of lymphomas. Consequently, HDAC inhibitors (HDACIs), a class of gene ex...
| 出版年: | Cancer Biology & Medicine |
|---|---|
| 主要な著者: | , |
| フォーマット: | 論文 |
| 言語: | 英語 |
| 出版事項: |
China Anti-Cancer Association
2012-06-01
|
| 主題: | |
| オンライン･アクセス: | http://www.cancerbiomed.org/index.php/cocr/article/view/14 |